Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 30.30
0.00 (0.00%)
Sep 24, 2026, 5:18 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 41.62 million as of September 24, 2026. Its market cap has increased by 91.77% in one year.
Market Cap
41.62M
Enterprise Value
43.59M
Revenue
18.44M
Ranking
n/a
PE Ratio
14.90
Stock Price
30.30
ChartMarket Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 41.62M, a decrease of -63.41%. That is a compound annual growth rate of -11.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 41.62M | 203.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 91.37M |
| Alzinova AB | 83.99M |
| Ascelia Pharma AB | 82.79M |
| Pila Pharma AB | 79.49M |
| Spago Nanomedical AB | 75.85M |
| Annexin Pharmaceuticals AB | 65.65M |
| AcouSort AB | 63.07M |
| Modus Therapeutics Holding AB | 57.84M |